CLEARCELL
LIVE

Serial Number

85389090

Owner

Clearbridge BioMedics Pte Ltd

Attorney

Jonathan Agmon

First Use Date

Aug 18, 2011

Filing Date

Aug 4, 2011

Add to watchlist:

No watchlists yet
View on USPTO

CLEARCELL Trademark

Serial Number: 85389090 • Registration: 4294265

CLEARCELL is a trademark filed by Clearbridge BioMedics Pte Ltd on August 4, 2011. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Clearbridge BioMedics Pte Ltd (2 trademarks)

81 Science Park Drive
Singapore 118257 , SG

Entity Type: 03

BIOLIDICS LIMITED (2 trademarks)

#02-07 Mapex
SINGAPORE 577177 , SG

Entity Type: 03

Trademark Details

Filing Date

August 4, 2011

Registration Date

February 26, 2013

First Use Anywhere

August 18, 2011

First Use in Commerce

August 31, 2011

Published for Opposition

December 11, 2012

Goods & Services

Instruments for scientific use in treatment of samples before analysis, namely, instruments for detecting and isolating intact circulating tumor cells and other rare cells from small quantities of blood, instruments for staining samples for identification, instruments for retrieving samples for molecular analysis, automated laboratory equipment for cutting samples; detecting apparatus for detecting containments and rare cells for scientific laboratory use; blood cell separation and analyzing apparatus, other than for medical use; [ cell counting units for laboratory use; cases adapted for cells, namely, cell culture plates and bio-chips used for cell cultures and examination, transportation case for cells; specimen collection containers for samples extracted from the body for laboratory use; computer programs for scientific data analysis; computer imaging systems comprising of scanners, digital video recorders and printers; computer programs for image processing; fluid sampling apparatus, namely, medical fluid injectors, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; ] automated analyses for body fluids, other than for medical use, namely, automatic fluid-composition control machines and instruments, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids or cells [; apparatus for measuring body fluids, namely, measuring couplings for measuring temperature, pressure, quantity and concentration of fluids in hydraulic or pneumatic systems, rheometers for measuring the viscosity and viscoelasticity of fluids ]

Medical devices for diagnosis of rare cells, medical devices for infusion of fluids and medicine and injection devices for administering drugs, medical cutting devices, [ medical device for detecting cancer, ] medical device for treating cancer; [ medical devices, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; medical devices for monitoring blood properties; medical devices for obtaining body fluid samples; medical devices, namely, sample preparation device for medical diagnostic uses; detection apparatus for medical use, namely, medical diagnostic apparatus for detecting cancer or rare cells, flow cytometers and flow-based analyzers providing cell and particle detection, for medical use; ] apparatus for blood tests, analysis and monitoring for medical use, namely, blood testing apparatus, namely, blood collecting tubes, blood testing apparatus, namely, blood sampling tubes, blood component separation apparatus for medical purposes, apparatus for blood analysis, filters for blood and blood components, medical devices for monitoring blood properties; blood cell separation and analyzing apparatus for medical use; [ apparatus for medical cell sampling, namely, cell culture chambers for cell sampling; medical apparatus, namely, tubing and syringes assembly set and electromechanical fluidic instrument, and other similar or related devices, which enable blood cells sampling; blood filtration and filtering apparatus; cell counting units for medical use, namely, cell culture chambers, flow cytometers and flow-based analyzers providing cell counting for medical use, single-cell analyses; cell culture apparatus for medical use, namely, cell culture chambers, cell plates and wells; filtering apparatus and automated analyzers for body fluids for medical use, namely, medical filters for blood and blood components, automated medical diagnostic instruments for the analysis of body fluids; implantable devices for medical use in measuring the composition of body fluids; meters for body fluids, namely, medical diagnostic instruments for measuring body fluids; medical infusion pumps; blood extraction devices; ] test and screening devices for medical purposes, namely, cancer diagnostics, cardiovascular diagnostics, fetal cell diagnostics, infectious disease diagnostics, and for screening thereof; medical diagnostic testing apparatus for cancer detection; diagnostic imaging apparatus for medical use; [ apparatus for analyzing images for medical use, namely, medical image processors, cell counting and staining devices; ] specimen collection devices for medical use in extracting samples from the body

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 21, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 21, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 21, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 21, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 21, 2026 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 21, 2022 NA89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 21, 2022 APRE
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 21, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 21, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 21, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 1, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 26, 2022 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 6, 2019 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 31, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 31, 2019 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 31, 2019 APRE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 15, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 15, 2019 COAR
TEAS SECTION 8 & 15 RECEIVED
Jan 3, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 26, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 26, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 11, 2012 NPUB
PUBLISHED FOR OPPOSITION
Dec 11, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 21, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 6, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 14, 2012 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 12, 2012 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 12, 2012 GNSL
SUSPENSION LETTER WRITTEN
Jul 12, 2012 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2012 CRFA
ASSIGNED TO LIE
Jun 19, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2011 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2011 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2011 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2011 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sep 4, 2011 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 4, 2011 PARI
NOTICE OF PSEUDO MARK MAILED
Aug 10, 2011 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2011 NWOS
NEW APPLICATION ENTERED
Aug 8, 2011 NWAP